Rosalind buys ISIS 36.1: Isis Pharmaceuticals Earns $1 Million From GSK for Advancing ISIS-TTR Rx
CARLSBAD, Calif., June 24, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that it has earned a $1 million milestone payment from GlaxoSmithKline (GSK) related to the advancement of the Phase 2/3 study of ISIS-TTR(Rx ... ...
20 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home